150 likes | 171 Views
NIDA NATIONAL INSTITUTE ON DRUG ABUSE. DIVISION OF NEUROSCIENCE AND BEHAVIORAL RESEARCH (DNBR). NATIONAL ADVISORY COUNCIL ON DRUG ABUSE FEBRUARY 14, 2001. NIDA NATIONAL INSTITUTE ON DRUG ABUSE. Reorganization of DNBR. WHY?. NIDA NATIONAL INSTITUTE ON DRUG ABUSE. OVERALL:.
E N D
NIDA NATIONAL INSTITUTE ON DRUG ABUSE DIVISION OF NEUROSCIENCE AND BEHAVIORAL RESEARCH (DNBR) NATIONAL ADVISORY COUNCIL ON DRUG ABUSE FEBRUARY 14, 2001
NIDA NATIONAL INSTITUTE ON DRUG ABUSE Reorganization of DNBR WHY?
NIDA NATIONAL INSTITUTE ON DRUG ABUSE OVERALL: More efficientlyidentify the cause and consequence of substance abuse in order to improve treatment
NIDA NATIONAL INSTITUTE ON DRUG ABUSE OFFICE OF DNBR DIRECTOR Director: Dr. Glen Hanson Deputy Director for Program: Dr. David Shurtleff Deputy Director for Science and Technology Development: Dr. Karen Skinner Associate Director for Neuroscience Coordination: Dr. Roger Brown Special Assistant and Training Coordinator: Dr. Charles Sharp Deputy to Training Coordinator: Beth Babecki
NIDA NATIONAL INSTITUTE ON DRUG ABUSE • Organized into 5 branches • to reflect contemporary strategies • and technologies • Areas of interest assigned as • they relate to basic science • issues
NIDA NATIONAL INSTITUTE ON DRUG ABUSE • Behavioral and Cognitive Science Research Branch Antecedent and consequent behavioral and cognitive factors to drug abuse, electro- physiological and systems processes and computational modeling Acting Chief: Dr. Minda Lynch Program Officers: Drs. Paul Schnur, Susan Volman & Cora Lee Wetherington
NIDA NATIONAL INSTITUTE ON DRUG ABUSE • Chemistry and Physiological • Systems Research Branch Analytical methods, basic chemistry, pharmacokinetics, perinatal effects, AIDS, neuroimmune function, and peripheral physiological systems Chief: Dr. Rao Rapaka Program Officers: Dr. Paul Hillary, Pushpa Thadani and Hari Singh
NIDA NATIONAL INSTITUTE ON DRUG ABUSE • Pharmacology, Integrative and • Cellular Neurobiology Research • Branch Neuroendocrine modulation, cellular neuro- pharmacology, mechanisms of neurotrans- mission, neuropasticity, neurotoxicity and neuroprotection Acting Chief: Dr. Nancy Pilotte Program Officers: Drs. Jerry Frankenheim and Geraline Lin
NIDA NATIONAL INSTITUTE ON DRUG ABUSE • Genetics and Molecular Neuro- • biology Research Branch Genotypic and phenotypic factors, trans- criptional regulation, applied proteomics and basic cellular mechanisms Acting Chief: Dr. Jonathan Pollock Program Officers: Dr. Rebekah Rasooly, Two positions to be filled
NIDA NATIONAL INSTITUTE ON DRUG ABUSE Translational Research Branch Applied cognition, analgesic systems, neuro- imaging, technology development, clinical application of basic science, cooperative interest with other divisions, institutes and private sector Special interest:nicotine-related issues, pain, and frontal lobe mechanisms
Acting Chief: Dr. David Thomas Program Officers: Drs. Thomas Aigner and Herb Weingartner NIDA NATIONAL INSTITUTE ON DRUG ABUSE Translational Research Branch
NIDA NATIONAL INSTITUTE ON DRUG ABUSE MAJOR OBJECTIVES:
NIDA NATIONAL INSTITUTE ON DRUG ABUSE • Factors contributing toaddiction transition • Neural development and its role in • vulnerability to addiction • Genetics of vulnerability • Basic cognitive & behavioral processes • related to drug abuse • Use of emerging technologies (e.g. gene • arrays)to study the addiction • Proteomics to appreciate the role of proteins in the • addiction process • Translation
NIDA NATIONAL INSTITUTE ON DRUG ABUSE INITIATIVES • RFA initiatives -Insertional Mutagenesis -Cutting Edge -GHB Initiative - Computational Supplement - Transition to Addiction • Anticipated initiatives - Cognition and Frontal Lobes in Addiction - Protein Trafficking and Drugs of Abuse - Nicotine Workgroup (Translational Model)
NIDA NATIONAL INSTITUTE ON DRUG ABUSE QUESTIONS?